Efficacy and Safety of Voriconazole Prophylaxis in Pedeatric Patients with Acute Myeloid Leukemia in Egypt

被引：0
|
作者：
Madney, Y. [1 ,2 ]
Arafah, O. [1 ,2 ]
Hafez, H. [1 ,2 ]
Shalaby, L. [1 ,2 ]
Zaki, I. [1 ,2 ]
El-Mahalawy, H. [2 ]
机构：
[1] Children Canc Hosp Egypt, Pediat Oncol, Cairo, Egypt
[2] Natl Canc Inst, Pediat Oncol, Cairo, Egypt
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-436
引用
收藏
页码：S365 / S366
页数：2
相关论文
共 50 条
  • [31] Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplant in Patients with Acute Myeloid Leukemia
    Tschernia, Nicholas P.
    Kumar, Vaibhav
    Moore, Dominic T.
    Vincent, Benjamin G.
    Coombs, Callie C.
    Van Deventer, Hendrik
    Foster, Matthew C.
    DeZern, Amy E.
    Luznik, Leo
    Riches, Marcie L.
    Serody, Jonathan S.
    Gojo, Ivana
    Zeidner, Joshua F.
    BLOOD, 2020, 136
  • [32] Efficacy and Safety of Bemcentinib in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Failing Hypomethylating Agents
    Kubasch, Anne Sophie
    Peterlin, Pierre
    Cluzeau, Thomas
    Gotze, Katharina S.
    Sockel, Katja
    Teipel, Raphael
    Jentzsch, Madlen
    Kayser, Sabine
    Attalah, Habiba
    Chermat, Fatiha
    Gloaguen, Silke
    Jersemann, Katja
    Schipp, Dorothea
    Giagounidis, Aristoteles
    McPherson, Stuart
    Tirado-Gonzalez, Irene
    van de Loosdrecht, Arjan
    Fenaux, Pierre
    Platzbecker, Uwe
    Medyouf, Hind
    Ades, Lionel
    BLOOD, 2020, 136
  • [33] Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia
    Lehrnbecher, Thomas
    Sung, Lillian
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (06) : 819 - 830
  • [34] A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
    Liao, Dan
    Wang, Mengyao
    Liao, Yi
    Li, Jun
    Niu, Ting
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia
    Venton, G.
    Adam, H.
    Colle, J.
    Labiad, Y.
    Mercier, C.
    Ivanov, V.
    Suchon, P.
    Fanciullino, R.
    Farnault, L.
    Costello, R.
    MEDECINE ET MALADIES INFECTIEUSES, 2016, 46 (04): : 226 - 229
  • [36] Feasibility, Efficacy, and Adverse Effects of Outpatient Antibacterial Prophylaxis in Children With Acute Myeloid Leukemia
    Inaba, Hiroto
    Gaur, Aditya H.
    Cao, Xueyuan
    Flynn, Patricia M.
    Pounds, Stanley B.
    Avutu, Viswatej
    Marszal, Lindsay N.
    Howard, Scott C.
    Pui, Ching-Hon
    Ribeiro, Raul C.
    Hayden, Randall T.
    Rubnitz, Jeffrey E.
    CANCER, 2014, 120 (13) : 1985 - 1992
  • [37] Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis
    Cudillo, L
    Girmenia, C
    Santilli, S
    Picardi, A
    Dentamaro, T
    Tendas, A
    de Fabritiis, P
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (08) : 1212 - 1213
  • [38] Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia
    van der Heiden, PLJ
    Jedema, I
    Willemze, R
    Barge, RMY
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) : 409 - 413
  • [39] The efficacy and safety of imatinib in adult patients with C-Kit positive acute myeloid leukemia.
    Kindler, T
    Breitenbuecher, F
    Marx, A
    Beck, J
    Hess, G
    Weinkauf, B
    Duyster, J
    Peschel, C
    Kirkpatrick, CJ
    Theobald, M
    Gschaidmeier, H
    Huber, C
    Fischer, T
    BLOOD, 2003, 102 (11) : 871A - 871A
  • [40] Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
    D A Pollyea
    H E Kohrt
    L Gallegos
    M E Figueroa
    O Abdel-Wahab
    B Zhang
    S Bhattacharya
    J Zehnder
    M Liedtke
    J R Gotlib
    S Coutre
    C Berube
    A Melnick
    R Levine
    B S Mitchell
    B C Medeiros
    Leukemia, 2012, 26 : 893 - 901
12345